Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-22-005731
Filing Date
2022-05-02
Accepted
2022-05-02 16:03:08
Documents
11
Period of Report
2022-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A endra_14a.htm DEF 14A 394275
2 endra_14aimg25.jpg GRAPHIC 3421
3 endra_14aimg24.jpg GRAPHIC 2243
4 endra_14aimg23.jpg GRAPHIC 1313
5 endra_14aimg22.jpg GRAPHIC 1001
6 endra_14aimg21.jpg GRAPHIC 1070
7 endra_14aimg20.jpg GRAPHIC 1233
8 endra_14aimg19.jpg GRAPHIC 4915
9 endra_14aimg13.jpg GRAPHIC 7372
10 endra_14aimg12.jpg GRAPHIC 7344
11 endra_14aimg11.jpg GRAPHIC 6998
  Complete submission text file 0001654954-22-005731.txt   447526
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37969 | Film No.: 22881849
SIC: 3845 Electromedical & Electrotherapeutic Apparatus